Quick Answer
Phio Pharmaceuticals Corp. reported Net Income of -$8.70 million for fiscal year 2025.
Phio Pharmaceuticals Corp. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$8.70M | -21.7% |
| 2024 | -$7.15M | +34.0% |
| 2023 | -$10.83M | +5.7% |
| 2022 | -$11.48M | +13.6% |
| 2021 | -$13.29M | -51.1% |
| 2020 | -$8.79M | +1.3% |
| 2019 | -$8.91M | -21.0% |
| 2018 | -$7.36M | +40.9% |
| 2017 | -$12.45M | -38.4% |
| 2016 | -$8.99M | +12.0% |
| 2015 | -$10.22M | -16.2% |
| 2014 | -$8.80M | +57.9% |
| 2013 | -$20.93M | -62.5% |
| 2012 | -$12.88M | -407.7% |
| 2011 | -$2.54M | +78.8% |
| 2010 | -$11.99M | +34.8% |
| 2009 | -$18.39M | -27.9% |
| 2008 | -$14.37M | -30.8% |
| 2007 | -$10.99M | -357.0% |
| 2006 | -$2.40M | -8.9% |
| 2005 | -$2.21M | +32.5% |
| 2004 | -$3.27M | -3576.4% |
| 2003 | -$89.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.39M | -57.0% | -10.4% |
| June 30, 2025 | -$2.17M | -17.3% | -22.4% |
| March 31, 2025 | -$1.77M | +17.9% | -16.1% |
| September 30, 2024 | -$1.52M | +45.2% | +17.4% |
| June 30, 2024 | -$1.85M | +27.6% | +14.3% |
| March 31, 2024 | -$2.15M | +40.2% | +22.5% |
| September 30, 2023 | -$2.78M | +22.3% | -9.1% |
| June 30, 2023 | -$2.55M | -0.7% | +29.2% |
- Phio Pharmaceuticals Corp. showed a decrease of -21.7% in Net Income compared to the prior fiscal year.
- Over the 2003–2025 period, Phio Pharmaceuticals Corp.’s net income has declined by 9673.0% (from -$89.0 thousand to -$8.70 million).
- The most recent figure is from Phio Pharmaceuticals Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: